Skip to main content

Table 3 Univariable analysis to identify factors associated to malaria chemoprophylaxis recommendation among individuals attended at the Instituto de Infectologia Emílio Ribas, in São Paulo, Brazil, from January 2006 to December 2010

From: Pre-travel malaria chemoprophylaxis counselling in a public travel medicine clinic in São Paulo, Brazil

Variables Chemoprophylaxis recommendation OR (CI 95%)
Yes (n;  %) No (n;  %)
Gender
Male 163 (55.8) 1220 (48.0) 1
Female 129 (44.2) 1324 (52.0) 1.37 (1.07–1.75)
Age group
<Median 165 (56.5) 1253 (49.3) 1
≥Median 127 (43.5) 1291 (50.7) 1.34 (1.05–1.71)
Schooling (years; 90.3%)
<8 8 (2.9) 128 (5.6) 1
8–11 40 (14.7) 447 (19.6) 0.70 (0.32–1.53)
≥12 225 (82.4) 1706 (74.8) 0.47 (0.23–0.98)
Any immunosupressive condition
No 286 (97.9) 2483 (97.6)
Yes 6 (2.1) 61 (2.4) 1.17 (0.50–2.73)
HIV infection
No 290 (99.3) 2512 (98.7)
Yes 2 (0.7) 32 (1.3) 1.85 (0.44–7.75)
Diabetes mellitus
No 288 (98.6) 2510 (98.7)
Yes 4 (1.4) 34 (1.3) 0.97 (0.34–2.77)
Depression
No 283 (96.9) 2459 (96.7)
Yes 9 (3.1) 85 (3.3) 1.87 (0.54–2.18)
Travel reason
Study or work 137 (47.2) 1343 (53.3)
Tourism 125 (43.1) 888 (35.3) 0.72 (0.56–0.94)
Multiples or others 28 (9.7) 288 (11.4) 1.05 (0.68–1.61)
Travel destination
Africa 183 (62.9) 511 (20.3)
Asia 30 (10.3) 387 (15.5) 4.62 (3.07–6.95)
Brazil 30 (10.3) 392 (15.6) 4.67 (3.11–7.04)
Latin American endemic countries 11 (3.8) 205 (8.2) 6.67 (3.55–12.53)
Others 37 (12.7) 1017 (40.5) 9.84 (6.81–14.23)
Accomodation type 2512
Hotel or hostel 79 (32.8) 775 (35.2)
Others 162 (67.2) 1428 (64.8) 0.90 (0.68–1.19)
Length of stay (in days)
≤30 154 (54.2) 1063 (45.0)
31–180 104 (36.6) 701 (29.7) 0.98 (0.75–1.27)
>180 26 (9.2) 598 (25.3) 3.33 (2.17–5.11)
  1. CI confidence interval